Page 32 - Bese News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bese. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bese Today - Breaking & Trending Today

Pfizer Drops Twice-Daily Version of Obesity Pill Over Side Effects

Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies after most patients dropped out of its midstage trial with high rates of side effects such as nausea and vomiting. ....

New York , United States , Steve Scala , Novo Nordisk Wegovy , Manas Mishra , Eli Lilly , Eli Lilly Mounjaro , Carter Gould , Albert Bourla , Novo Nordisk , Michael Erman , Anild Silva , Bill Berkrot , Weight Management , Adverse Effects , Side Effects , Patient Safety , Glp 1 Receptor Agonists , Glucagon Like Peptide 1 Receptor Agonists , Weight Loss , Drug Development ,

US Obesity Docs Expect Zepbound to Show Heart Benefit

Some leading US obesity specialists say they expect Eli Lilly’s powerful weight-loss drug Zepbound will produce the same or similar heart benefits as Novo Nordisk’s popular Wegovy. ....

Rohit Kedia , Eli Lilly , Caroline Humer , Lilly Mounjaro , Edmond Wickham , Patrick Wingrove , Astrazeneca Farxiga , Lilly Jardiance , Stanford University , Virginia Commonwealth University , Drug Administration On Nov , Boehringer Ingelheim , Novo Nordisk , Virginia Commonwealth , Drug Administration , Emily Field , Chad Weldy , Bill Berkrot , Weight Management , Cardiovascular Disease , Vd Cardiovascular Disease , Glp 1 Receptor Agonists , Glucagon Like Peptide 1 Receptor Agonists , Weight Loss ,

EU Watchdog Seeks More Safety Data From GLP-1 Drugmakers

The EU s drug watchdog will request more data from makers of a class of diabetes and weight-loss drugs including Ozempic and Wegovy to further investigate suicidal thoughts in some patients taking them. ....

United Kingdom , United States , Eli Lilly Trulicity , Novo Rybelsus , Sanofi Suliqua , Kirsten Donovan , Eli Lilly , Yadarisa Shabong , Frances Kerry , Novo Saxenda , Astrazeneca Bydureon , Pharmacovigilance Risk Assessment Committee , Drug Administration , Icelandic Medicines Agency , Novo Nordisk , European Medicines Agency , Risk Assessment Committee , Weight Management , Weight Loss , Drug Regulation , Glp 1 Receptor Agonists , Glucagon Like Peptide 1 Receptor Agonists , Patient Safety , Adverse Effects , Side Effects ,

Launches of Novo Nordisk's Weight-Loss Drug Wegovy

Novo Nordisk is pushing ahead with the launches of weight-loss drug Wegovy in Europe and Asia, even as it struggles to keep up with demand. ....

United States , United Kingdom , Ludwig Burger , Jan Harvey , Elviira Luoma , Milla Nissi , Agata Rybska , Icelandic Medicines Agency , Novo Nordisk , Norwegian Medicines Agency , National Health Service , Online Pharmacy , United Kingdom Based , Medicines Agency , Weight Management , Weight Loss , Glp 1 Receptor Agonists , Glucagon Like Peptide 1 Receptor Agonists , Drug Shortages , Medication Shortages , Health Insurance ,

ACC/AHA Issue Updated Atrial Fibrillation Guideline

The new guideline proposes a new way to classify AF, emphasizes the importance of early rhythm control and lifestyle modification, and gives catheter ablation a Class 1 indication. ....

United States , Jose Joglar , American College Of Cardiology , Ut Southwestern Medical Center , American Heart Association , American College Of Chest Physicians , Heart Rhythm Society , Journal Of The American College Cardiology , American College , Chest Physicians , Atrial Fibrillation , Medical Center , F Atrial Fibrillation , Clinical Guidelines , Ischemic Stroke , Acute Stroke , Catheter Ablation , Heart Failure , Physical Activity , Renal Disease , Kidney Disease , Kidney Disorder , Renal Disorder , Erebrovascular Accident , Va Cerebrovascular Accident , Nt Ears ,